Osteoclast diseases
- PMID: 12879419
- DOI: 10.1002/jemt.10375
Osteoclast diseases
Abstract
Osteoclasts are the only cells capable of resorbing mineralised bone, dentine and cartilage. Osteoclasts act in close concert with bone forming osteoblasts to model the skeleton during embryogenesis and to remodel it during later life. A number of inherited human conditions are known that are primarily caused by a defect in osteoclasts. Most of these are rare monogenic disorders, but others, such as the more common Paget's disease, are complex diseases, where genetic and environmental factors combine to result in the abnormal osteoclast phenotype. Where the genetic defect gives rise to ineffective osteoclasts, such as in osteopetrosis and pycnodysostosis, the result is the presence of too much bone. However, the phenotype in many osteoclast diseases is a combination of osteosclerosis with osteolytic lesions. In such conditions, the primary defect is hyperactivity of osteoclasts, compensated by a secondary increase in osteoblast activity. Rapid progress has been made in recent years in the identification of the causative genes and in the understanding of the biological role of the proteins encoded. This review discusses the known osteoclast diseases with particular emphasis on the genetic causes and the resulting osteoclast phenotype. These human diseases highlight the critical importance of specific proteins or signalling pathways in osteoclasts.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.J Pathol. 2006 May;209(1):114-20. doi: 10.1002/path.1953. J Pathol. 2006. PMID: 16482498
-
Genetic regulation of osteoclast development and function.Nat Rev Genet. 2003 Aug;4(8):638-49. doi: 10.1038/nrg1122. Nat Rev Genet. 2003. PMID: 12897775 Review.
-
Osteoclast diseases and dental abnormalities.Arch Oral Biol. 2005 Feb;50(2):115-22. doi: 10.1016/j.archoralbio.2004.11.016. Epub 2005 Jan 18. Arch Oral Biol. 2005. PMID: 15721137 Review.
-
Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.Bone. 2005 Jan;36(1):159-72. doi: 10.1016/j.bone.2004.09.020. Epub 2004 Nov 24. Bone. 2005. PMID: 15664014
-
New knowledge on the origin, function and fate of osteoclasts.Clin Orthop Relat Res. 1981 Jul-Aug;(158):252-69. Clin Orthop Relat Res. 1981. PMID: 6268344 Review.
Cited by
-
Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton.Int J Endocrinol. 2015;2015:372156. doi: 10.1155/2015/372156. Epub 2015 Mar 19. Int J Endocrinol. 2015. PMID: 25873953 Free PMC article. Review.
-
Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.Hum Mol Genet. 2007 Feb 15;16(4):410-23. doi: 10.1093/hmg/ddl474. Epub 2007 Jan 8. Hum Mol Genet. 2007. PMID: 17210673 Free PMC article.
-
The osteoclast--what's new?Skeletal Radiol. 2011 Sep;40(9):1137-40. doi: 10.1007/s00256-011-1180-9. Epub 2011 Aug 17. Skeletal Radiol. 2011. PMID: 21847745 Review.
-
RANK, RANKL and osteoprotegerin in bone biology and disease.Curr Rev Musculoskelet Med. 2009 Mar;2(1):56-64. doi: 10.1007/s12178-009-9046-7. Epub 2009 Mar 10. Curr Rev Musculoskelet Med. 2009. PMID: 19468919 Free PMC article.
-
The T-cell oncogene Tal2 Is a Target of PU.1 and upregulated during osteoclastogenesis.PLoS One. 2013 Sep 26;8(9):e76637. doi: 10.1371/journal.pone.0076637. eCollection 2013. PLoS One. 2013. PMID: 24086757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical